The Manufacturers Life Insurance Company lifted its position in Ralliant Corporation (NYSE:RAL – Free Report) by 57.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 181,407 shares of the company’s stock after purchasing an additional 66,443 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Ralliant were worth $7,545,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Teacher Retirement System of Texas grew its stake in Ralliant by 6.9% during the fourth quarter. Teacher Retirement System of Texas now owns 570,878 shares of the company’s stock worth $29,063,000 after buying an additional 36,800 shares during the last quarter. Alpha Omega Wealth Management LLC raised its stake in shares of Ralliant by 615.8% in the fourth quarter. Alpha Omega Wealth Management LLC now owns 40,291 shares of the company’s stock valued at $2,051,000 after acquiring an additional 34,662 shares during the last quarter. Phocas Financial Corp. raised its stake in shares of Ralliant by 81.2% in the fourth quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock valued at $7,999,000 after acquiring an additional 70,403 shares during the last quarter. Walleye Capital LLC acquired a new position in shares of Ralliant in the 1st quarter worth approximately $4,525,000. Finally, Fifth Third Bancorp boosted its holdings in shares of Ralliant by 3,988.0% in the 1st quarter. Fifth Third Bancorp now owns 32,132 shares of the company’s stock worth $1,336,000 after acquiring an additional 31,346 shares in the last quarter.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a report on Friday. Barclays increased their target price on Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a report on Wednesday, May 13th. Citigroup raised their target price on Ralliant from $81.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Wall Street Zen raised Ralliant from a “hold” rating to a “strong-buy” rating in a report on Monday. Finally, Morgan Stanley upped their price target on shares of Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.70.
Ralliant Trading Up 3.0%
RAL stock opened at $67.13 on Wednesday. The company has a market cap of $7.43 billion, a P/E ratio of -6.19, a PEG ratio of 2.42 and a beta of 1.60. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $75.41. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. The business has a fifty day moving average of $67.37 and a 200-day moving average of $54.54.
Ralliant (NYSE:RAL – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities research analysts expect that Ralliant Corporation will post 2.87 EPS for the current year.
Ralliant Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio is presently -1.84%.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Stories
- Five stocks we like better than Ralliant
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
